Clario

Clario is a global leader in clinical trial endpoint technologies, specializing in solutions that enhance efficacy, ensure safety, and improve patient quality of life throughout drug development. Leveraging over 50 years of experience and a portfolio spanning more than 26,000 clinical trials in over 100 countries, Clario delivers a comprehensive suite of evidence generation tools for clinical trial management. Their offerings encompass advanced software, connected devices, and artificial intelligence across therapeutic areas such as cardiac safety, electronic Clinical Outcome Assessment (eCOA), medical imaging, precision motion, and respiratory endpoints.

Clario’s platform is engineered to support site-based, hybrid, and fully decentralized trials, providing flexibility and reliability for sponsors, sites, and contract research organizations (CROs). The company’s scientific and regulatory expertise ensures the precision and reliability of clinical evidence, while its global operational infrastructure enables rapid deployment and localization, including support in over 100 languages.

A core focus for Clario is simplifying the clinical trial process, driving compliance and retention through integrated training, 24/7 support, and user-friendly technologies. The company’s solutions are designed to empower patient choice, foster diversity in clinical trials, and ultimately improve health equity by prioritizing both physical and mental well-being of participants.

Keywords: clinical trial technology, endpoint solutions, drug development, patient safety, eCOA, medical imaging, decentralized trials, regulatory expertise, global deployment, artificial intelligence, cardiac safety, precision motion, respiratory endpoints, health equity, compliance, patient-centric